Data

Targeted Screening for Congenital Cytomegalovirus-related Hearing loss in infants in Western Australia

Perth Childrens Hospital

Dataset description

Aim(s): This project aims to examine the feasibility of establishing a state-wide screening program in WA to detect congenital CMV-related hearing loss in high-risk infants. The project does not aim to determine if early treatments are effective, this is outside of the scope of the study. Primary Objectives: 1. To determine the incidence of congenital CMV infection in those infants who fail their newborn hearing screen in WA 2. To monitor the clinical progression of these patients/participants over time and their patterns of hearing loss to be able to better understand the disease in WA Secondary objectives: 1. a) To identify and address potential barriers to early detection of cCMV (less than 21 days) in order to facilitate feasible (cost-effective, minimally invasive) diagnosis via a saliva swab b) To determine whether early diagnosis has the potential to make time-critical treatment possible (within 30 days). 2. If targeted testing is found to be feasible - to create and implement a protocol which forms a clinical pathway for targeted testing of infants at high-risk of cCMV in WA. Hypothesis: We hypothesise that timely targeted cCMV screening is both important and feasible to implement into WA Newborn Hearing Screening Guidelines.

Date Information

Submitted from 2026-02-09
Issued from 2024
Click to explore relationships graph
 

Source Study

Trial acronym

Not available

Trial ID

ACTRN12621000484842

Funding

Charities/Societies/Foundations, the Garnett-Passe Foundation

Scientific enquiries

Dr Allison Reid

Brief Summary

Aim(s): This project aims to examine the feasibility of establishing a state-wide screening program in WA to detect congenital CMV-related hearing loss in high-risk infants. The project does not aim to determine if early treatments are effective, this is outside of the scope of the study. Primary Objectives: 1. To determine the incidence of congenital CMV infection in those infants who fail their newborn hearing screen in WA 2. To monitor the clinical progression of these patients/participants o .... Read more

Key Inclusion Criteria

During the 2 year study 1. all infants born in Western Australia undergoing newborn hearing screening which results in a 'refer' (fail) result in one or both ears 2. Are age less than day 11 for rural/remote infants and day 14 for infants in metropolitan area on the day the 'refer' result is received by the study team 3. Has a legally acceptable representative able to provide informed consent on behalf of the infant

Key Exclusion Criteria

1. Newborn hearing screen ‘refer’ result but infant aged over 11 days of age (rural/remote participants) and 14 days of age (metropolitan participant) 2. Medically unwell – although not specifically excluded from the study some Infants may be too unwell to reasonably take part. In consultation with the treating team, the research team would consider the appropriateness of approaching the guardians. 3. Lack of a legally acceptable representative able to provide informed consent on behalf of the i .... Read more

Can healthy volunteers participate?

No

Population

Sample Size    204

Min. age    No limit

Max. age    14 Days

Sex    Both males and females

Condition category    Congenital CMV-related Hearing Loss

Condition code    Ear , Infection

Intervention

Intervention code Early detection / Screening

Targeted testing of infants for congenital cytomegalovirus (cCMV). Infants are targeted using the newborn hearing screen result. Infants who fail ('refer') on newborn hearing screening are at increased risk of cCMV and (their parents/guardians) will be contacted to offer enrolment in the study - and testing for cCMV. Currently testing is not routinely offered at this time point. All infants in the state (meeting eligibility criteria) will be offered enrolment. cCMV testing (saliva and urine) pro ....
Read more

Comparison

Control group Uncontrolled

No control

Outcomes

Outcome: To assess whether targeted congenital cytomegalovirus testing is able to be completed by day 21 of life in Infants at high-risk of the virus across Western Australia Used to assess this: The proportion of infants unable to be recruited due to delayed NBHS testing/delayed communication of these results/unable to contact the parents or guardians by day 14 of life/infants who do not attend testing centres despite being enrolled The electronic hospital results platform is ....
Read more

The data-sharing statement for this study is currently unavailable.

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see anzctr.org.au

How is Heath Data Australia supporting health research?

To assist secondary data users in understanding the real-world impact of health and medical research data sharing, the Australian Research Data Commons (ARDC) has created an online guide that outlines a theoretical framework for four key data reuse scenarios. This practical guide was extracted from research papers, and consultation with stakeholders and the research community.

Read the guide

How to access data via Health Data Australia

With Health Data Australia, researchers can explore descriptions of data from our publishing partners, identify relevant datasets, and request access. These requests will then be forwarded to the data owner for review.

To start requesting data, simply login with your AAF account.

Learn more